Grants in the Netherlands
Explore grants for companies in the Netherlands. This directory includes national and regional funding from Dutch innovation agencies, research funders and foundations, EU and international programs open to applicants in the Netherlands, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at the Netherlands come first.
Showing 1,633-1,656 of 2,095 grants
MSCA Postdoctoral Fellowships 2027
European Commission · European Union
Pays a postdoctoral researcher's fellowship at a host organisation in Europe, or abroad with a mandatory return phase, to build international research experience.
Integrating Biospecimen Science Approaches into Clinical Assay Development
NIH · United States
Funds research into how preanalytical handling of biopsies and other biospecimens distorts biomarker results used in clinical assays.
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies
NIH · United States
Funds technology anywhere in the connectomics pipeline — collection, reconstruction, analysis, dissemination — to make brain wiring diagrams faster and cheaper.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders
NIH · United States
Funds a confirmatory efficacy trial of a non-drug treatment or preventive intervention for mental disorders, in adults or children.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33)
NIH · United States
Funds three years replicating target engagement for a psychosocial intervention and testing whether that engagement tracks clinical change.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33)
NIH · United States
Funds two years establishing that a psychosocial intervention hits its target, then three replicating it and linking it to clinical change.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
Effectiveness Trials to Test Mental Health System Interventions
NIH · United States
Funds a feasibility and infrastructure phase, then a well-powered trial, of an intervention aimed at how mental health services are organised and delivered.
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions
NIH · United States
Funds a definitive trial of a mental health treatment or service in real community and practice settings, powered to settle the question.
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions
NIH · United States
Funds a pilot effectiveness study of a mental health intervention — and requires it to test whether the intervention engages its presumed mechanism.
NEI Research Grant for Vision-Related Secondary Data Analysis
NIH · United States
Funds secondary analysis of vision-health data that already exists, and new statistical methods for getting more out of it.
Early-Stage Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds early-stage development of new cancer-research software tools, from first prototype to their first real users.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery
NIH · United States
Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification
NIH · United States
Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies
NIH · United States
Funds the pharmacology and animal efficacy work that shows a neurological drug candidate is worth developing further.
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34)
NIH · United States
Funds the same preparatory work before a cancer prevention trial, as an ordinary grant rather than a cooperative agreement.
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34)
NIH · United States
Funds the preparatory study that answers the unknowns — accrual, endpoints, statistics, operations — before a cancer prevention trial is finalised.
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain
NIH · United States
Funds computational tools, models and theories for understanding brain circuits, built to be shared broadly with the research community.
Basic Research in Cancer Health Disparities (R21)
NIH · United States
Funds early-stage mechanistic work on the biological and genetic causes of cancer health disparities, on a shorter and smaller footing.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.